Decreases the percentage of KCs and the activation of M1 macrophages in liver with inhibited TLR4/NF-κB signaling pathway. Alleviates liver inflammation in NAFLD mice. The gene discussed is TBCE; the disease is metabolic dysfunction-associated steatotic liver disease.